Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers

被引:114
|
作者
Hosoya, K
Kim, KJ
Lee, VHL
机构
[1] UNIV SO CALIF,SCH PHARM,DEPT PHARMACEUT SCI,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT MED PHYSIOL & BIOPHYS & BIOMED ENGN,WILL ROGERS INST PULM RES CTR,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,SCH ENGN,DEPT MED PHYSIOL & BIOPHYS & BIOMED ENGN,WILL ROGERS INST PULM RES CTR,LOS ANGELES,CA 90033
关键词
Caco-2 cell monolayer; culture age; cyclosporin A; P-glycoprotein; verapamil;
D O I
10.1023/A:1016005212640
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To determine whether the expression and activity of the P-glycoprotein (P-GP) drug efflux pump vary with the culture age of Caco-2 cell monolayers. Methods. Caco-2 cell monolayers were grown for 3-27 days on tissue culture-treated Transwells. P-GP eMux function was determined by measuring transmonolayer fluxes of cyclosporin A (CsA) and verapamil, while P-GP expression level was evaluated by Western blot analysis using monoclonal antibody C219. Results. The apparent permeability coefficient (Papp) of CsA (0.5 mu M) in the basolateral-to-apical (B-->A) direction increased with culture age and was higher than the apical-to-basolateral (A-->B) direction at all times. Net secretory Papp significantly increased from day 17 onward compared to that observed during day 3 through 13. Verapamil (100 mu M) significantly inhibited CsA transport in the B-->A direction from day 17 to 27, while elevating CsA transport in the A-->B direction from day 6 to 27. interestingly, the Papp of verapamil (0.5 mu M) in the B-->A direction was significantly higher than in the A-->B direction from day 6 to 27, rendering increases in net secretory Papp of verapamil with culture age. Western analysis revealed that P-GP expression level was in the order of 4 weeks approximate to 1 week > 3 weeks > 2 weeks at equal loading of cell proteins. Conclusions. P-GP is continuously expressed throughout the culture period, but it may not be fully functional at an early age. Caco-2 cell monolayers of day 17 to 27 appear to be a good model to evaluate the functional role of P-GP in drug efflux.
引用
收藏
页码:885 / 890
页数:6
相关论文
共 50 条
  • [41] Efflux of sphingoid bases by P-glycoprotein in human intestinal Caco-2 cells
    Sugawara, T
    Kinoshita, M
    Ohnishi, M
    Tsuzuki, T
    Miyazawa, T
    Nagata, J
    Hirata, T
    Saito, M
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2004, 68 (12) : 2541 - 2546
  • [42] Inhibition of P-Glycoprotein Mediated Efflux in Caco-2 Cells by Phytic Acid
    Li, Lujia
    Fu, Qingxue
    Xia, Mengxin
    Xin, Lei
    Shen, Hongyi
    Li, Guowen
    Ji, Guang
    Meng, Qianchao
    Xie, Yan
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (04) : 988 - 998
  • [43] Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII-hMDR1-NKI and Caco-2 Cell Monolayers
    Meng, Zhou
    Le Marchand, Sylvain
    Agnani, Deep
    Szapacs, Matthew
    Ellens, Harma
    Bentz, Joe
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (02) : 145 - 151
  • [44] Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells
    Oka, A
    Oda, M
    Saitoh, H
    Nakayama, A
    Takada, M
    Aungst, BJ
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (03) : 393 - 396
  • [45] Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells
    Takano, M
    Hasegawa, R
    Fukuda, T
    Yumoto, R
    Nagai, J
    Murakami, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 358 (03) : 289 - 294
  • [46] Glyceollin Transport, Metabolism, and Effects on P-Glycoprotein Function in Caco-2 Cells
    Chimezie, Chukwuemezie
    Ewing, Adina C.
    Quadri, Syeda S.
    Cole, Richard B.
    Boue, Stephen M.
    Omari, Christopher F.
    Bratton, Melyssa
    Glotser, Elena
    Skripnikova, Elena
    Townley, Ian
    Stratford, Robert E., Jr.
    JOURNAL OF MEDICINAL FOOD, 2014, 17 (04) : 462 - 471
  • [47] Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors
    Cormet-Boyaka, E
    Huneau, JF
    Mordrelle, A
    Boyaka, PN
    Carbon, C
    Rubinstein, E
    Tomé, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2607 - 2611
  • [48] Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers:: role of P-glycoprotein and a novel Na+-dependent organic cation transport mechanism
    Bleasby, K
    Chauhan, S
    Brown, CDA
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) : 619 - 625
  • [49] Peripheral blood lymphocytes P-glycoprotein (P-gp, gp-170) expression in allogenic kidney transplant patients
    Kotrych, Katarzyna
    Masiuk, Marek
    Domanski, Leszek
    Rozanski, Jacek
    Drozdzik, Marek
    NEPHROLOGY, 2006, 11 (03) : 257 - 260
  • [50] Efflux Ratio Cannot Assess P-Glycoprotein-Mediated Attenuation of Absorptive Transport: Asymmetric Effect of P-Glycoprotein on Absorptive and Secretory Transport Across Caco-2 Cell Monolayers
    Matthew D. Troutman
    Dhiren R. Thakker
    Pharmaceutical Research, 2003, 20 : 1200 - 1209